Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-administration of Live Attenuated Dengue and Chikungunya Vaccines in Adults
NCT06973772Phase 3Not yet recruiting
- Sponsor
- Instituto Butantan
- Start
- Mar 2027
- Primary completion
- Jul 2027
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Butantan-DV, chikungunya vaccine (live) in dengue fever, Chikungunya (CHIKV), sponsored by Instituto Butantan. Planned start Mar 2027; status: not yet recruiting.
02
Drugs
Butantan-DVchikungunya vaccine (live)
03
Conditions
dengue feverChikungunya (CHIKV)
Beyond the preview
Go deeper on NCT06973772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06973772.